Wuhan Easy Diagnosis Biomedicine Co Ltd
SZSE:002932
Wuhan Easy Diagnosis Biomedicine Co Ltd
Cash from Financing Activities
Wuhan Easy Diagnosis Biomedicine Co Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Wuhan Easy Diagnosis Biomedicine Co Ltd
SZSE:002932
|
Cash from Financing Activities
-¥432.8m
|
CAGR 3-Years
-169%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
A
|
APT Medical Inc
SSE:688617
|
Cash from Financing Activities
-¥246.4m
|
CAGR 3-Years
-34%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Cash from Financing Activities
-¥1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-57%
|
CAGR 10-Years
-34%
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Cash from Financing Activities
-¥5.2B
|
CAGR 3-Years
-61%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
L
|
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
|
Cash from Financing Activities
-¥332.2m
|
CAGR 3-Years
19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-7%
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Cash from Financing Activities
¥10.7B
|
CAGR 3-Years
242%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Wuhan Easy Diagnosis Biomedicine Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
-432.8m
CNY
Based on the financial report for Dec 31, 2022, Wuhan Easy Diagnosis Biomedicine Co Ltd's Cash from Financing Activities amounts to -432.8m CNY.
What is Wuhan Easy Diagnosis Biomedicine Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-169%
The average annual Cash from Financing Activities growth rates for Wuhan Easy Diagnosis Biomedicine Co Ltd have been -169% over the past three years .